SCHEMBL6539381

SCHEMBL6539381

COc1ccc(C(=O)Nc2ccc(C[C@@H](CO)N(Cc3ccccc3)C[C@H](O)COc3ccccc3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 8/20 0.54
ADRB3 P13945 8/20 0.54
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
NPC1 O15118 2/20 0.46
RAB9A P51151 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 3/20 0.45
CYP1A2 P05177 2/20 0.45
ADRB2 P07550 1/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538889 0.93 ADRB1 (0.49) ADRB1ADRB3LMNAMEN1KMT2A
SCHEMBL6538732 0.93 ADRB1 (0.50) ADRB1ADRB3LMNANPC1RAB9A
SCHEMBL6538563 0.93 ADRB1 (0.54) ADRB1ADRB3LMNANPC1RAB9A
SCHEMBL6540060 0.92 ADRB1 (0.48) ADRB1ADRB3LMNANPC1RAB9A
SCHEMBL6539512 0.92 ADRB1 (0.52) ADRB1ADRB3LMNAMAPTNPC1
SCHEMBL6538485 0.91 ADRB1 (0.47) ADRB1ADRB3LMNANPC1RAB9A
SCHEMBL6538663 0.90 ADRB1 (0.48) ADRB1ADRB3LMNANPC1RAB9A
SCHEMBL6539792 0.90 ADRB1 (0.53) ADRB1ADRB3MAPTNPC1RAB9A
SCHEMBL6538597 0.88 NR1H4 (0.48) ADRB1ADRB3NPC1RAB9AMEN1
SCHEMBL6538833 0.85 ADRB3 (0.61) ADRB1ADRB3MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed
WO-2002024635-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-28 WO disclosed